Heart Rhythm

Article	Citations
Recognizing COVID-19–related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management	537
COVID-19 and cardiac arrhythmias	311
COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors	206
QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine/azithromycin	194
2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families	156
SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes	148
Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electroc	145
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review	127
Left bundle branch–optimized cardiac resynchronization therapy (LOT-CRT): Results from an international LBBAP collaborative study group	117
Physiology-based electrocardiographic criteria for left bundle branch capture	112
Clinical outcomes of left bundle branch area pacing compared to right ventricular pacing: Results from the Geisinger-Rush Conduction System Pacing Registry	110
The possible association between COVID-19 and postural tachycardia syndrome	105
Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials	103
Cryoballoon ablation of pulmonary veins for persistent atrial fibrillation: Results from the multicenter STOP Persistent AF trial	92
Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia	92
2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure	90
Cardiac radioablation—A systematic review	89
Clinical outcomes of conduction system pacing compared to biventricular pacing in patients requiring cardiac resynchronization therapy	79
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the State of Gen	79
Intermediate-term performance and safety of His-bundle pacing leads: A single-center experience	78
Leadless pacemakers reduce risk of device-related infection: Review of the potential mechanisms	76
Marshall bundle elimination, Pulmonary vein isolation, and Line completion for ANatomical ablation of persistent atrial fibrillation (Marshall-PLAN): Prospective, single-center study	74
Left bundle branch pacing compared to left ventricular septal myocardial pacing increases interventricular dyssynchrony but accelerates left ventricular lateral wall depolarization	73
Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection	73
Wearables in cardiology: Here to stay	68

Genetic susceptibility for COVID-19–associated sudden cardiac death in African Americans	65
A new smart wristband equipped with an artificial intelligence algorithm to detect atrial fibrillation	64
Epicardial course of the septopulmonary bundle: Anatomical considerations and clinical implications for roof line completion	64
Off-label dosing of non–vitamin K antagonist oral anticoagulants and clinical outcomes in Asian patients with atrial fibrillation	63
Postural orthostatic tachycardia syndrome as a sequela of COVID-19	58
Dysautonomia following COVID-19 is not associated with subjective limitations or symptoms but is associated with objective functional limitations	57
Fixation beats: A novel marker for reaching the left bundle branch area during deep septal lead implantation	56
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients	55
Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study	55
Generalizability of the CASTLE-AF trial: Catheter ablation for patients with atrial fibrillation and heart failure in routine practice	54
Real-world experience of leadless left ventricular endocardial cardiac resynchronization therapy: A multicenter international registry of the WiSE-CRT pacing system	53
Deep learning for comprehensive ECG annotation	52
Catheter ablation of atrial fibrillation using ablation index–guided high power (50 W) for pulmonary vein isolation with or without esophageal temperature probe (the AI-HP ESO II)	51
Acute and long-term results of bipolar radiofrequency catheter ablation of refractory ventricular arrhythmias of deep intramural origin	51
Effects of hydroxychloroquine treatment on QT interval	50
Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group	49
Electrophysiological characteristics of septal perforation during left bundle branch pacing	49
Esophageal temperature dynamics during high-power short-duration posterior wall ablation	48
Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator	47
Cardioneuroablation for vasovagal syncope: A systematic review and meta-analysis	43
The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up	43
A circadian clock in the sinus node mediates day-night rhythms in Hcn4 and heart rate	43
His-bundle and left bundle pacing with optimized atrioventricular delay achieve superior electrical synchrony over endocardial and epicardial pacing in left bundle branch block patients	43
Ablation strategies for intramural ventricular arrhythmias	42
High-throughput discovery of trafficking-deficient variants in the cardiac potassium channel KV11.1	41
Validation of an algorithm for continuous monitoring of atrial fibrillation using a consumer smartwatch	39
Rationale, considerations, and goals for atrial fibrillation centers of excellence: A Heart Rhythm Society perspective	38
Predictors of atrial mechanical sensing and atrioventricular synchrony with a leadless ventricular pacemaker: Results from the MARVEL 2 Study	38
Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis	37
His-bundle pacing vs biventricular pacing following atrioventricular nodal ablation in patients with atrial fibrillation and reduced ejection fraction: A multicenter, randomized, crossover study—The A	37
Ectopy-triggering ganglionated plexuses ablation to prevent atrial fibrillation: GANGLIA-AF study	37
Major adverse clinical events associated with implantation of a leadless intracardiac pacemaker	37
High-resolution, live, directional mapping	36
Bipolar radiofrequency ablation for ventricular tachycardias originating from the interventricular septum: Safety and efficacy in a pilot cohort study	36
Cardiac potassium inward rectifier Kir2: Review of structure, regulation, pharmacology, and arrhythmogenesis	36
High-power, short-duration atrial fibrillation ablations using contact force sensing catheters: Outcomes and predictors of success including posterior wall isolation	36
Durability of posterior wall isolation after catheter ablation among patients with recurrent atrial fibrillation	34
Filamin-C variant-associated cardiomyopathy: A pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death	34
Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019	34
Leadless left ventricular stimulation with WiSE-CRT System – Initial experience and results from phase I of SOLVE-CRT Study (nonrandomized, roll-in phase)	34
Mechanisms of atrial fibrillation in aged rats with heart failure with preserved ejection fraction	34
Temperature monitoring and temperature-driven irrigated radiofrequency energy titration do not prevent thermally induced esophageal lesions in pulmonary vein isolation: A randomized study controlled b	34
Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy	33
Combined local impedance and contact force for radiofrequency ablation assessment	33
Leadless atrioventricular synchronous pacing in an outpatient setting: Early lessons learned on factors affecting atrioventricular synchrony	32
Predictors of adverse outcome in patients with frequent premature ventricular complexes: The ABC-VT risk score	32
Outcomes of catheter ablation of ventricular arrhythmia originating from the left ventricular summit: A multicenter study	32
Behavior of the PR interval with increasing heart rate in patients with COVID-19	32
Temperature- and flow-controlled ablation/very-high-power short-duration ablation vs conventional power-controlled ablation: Comparison of focal and linear lesion characteristics	31
Ostial dimensional changes after pulmonary vein isolation: Pulsed field ablation vs radiofrequency ablation	31

A novel 9-partition method using fluoroscopic images for guiding left bundle branch pacing	31
Structure and function of the ventricular tachycardia isthmus	30
Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience	30
Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria	30
Enhanced electrocardiographic monitoring of patients with Coronavirus Disease 2019	30
Atrial fibrillation burden and heart failure: Data from 39,710 individuals with cardiac implanted electronic devices	29
Anatomic approach with bipolar ablation between the left pulmonic cusp and left ventricular outflow tract for left ventricular summit arrhythmias	29
Scar channels in cardiac magnetic resonance to predict appropriate therapies in primary prevention	29
Contrast-enhanced image-guided lead deployment for left bundle branch pacing	29
Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5	28
Axillary vein puncture guided by ultrasound vs cephalic vein dissection in pacemaker and defibrillator implant: A multicenter randomized clinical trial	28
Smartwatch-based detection of cardiac arrhythmias: Beyond the differentiation between sinus rhythm and atrial fibrillation	28
Atrioventricular junction ablation in patients with conduction system pacing leads: A comparison of His-bundle vs left bundle branch area pacing leads	28
Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram?	27
Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardia	27
Arrhythmia recurrence is more common in females undergoing multiple catheter ablation procedures for persistent atrial fibrillation: Time to close the gender gap	27
Appropriate and inappropriate shocks in hypertrophic cardiomyopathy patients with subcutaneous implantable cardioverter-defibrillators: An international multicenter study	26
Direct comparison of a novel antitachycardia pacing algorithm against present methods using virtual patient modeling	26
Incidence of arrhythmias and electrocardiographic abnormalities in symptomatic pediatric patients with PCR-positive SARS-CoV-2 infection, including drug-induced changes in the corrected QT interval	26
Age at diagnosis of Brugada syndrome: Influence on clinical characteristics and risk of arrhythmia	26
Letter to the Editor—Lifesaving therapy inhibition by phones containing magnets	26
Cardiac arrhythmias and sudden unexpected death in epilepsy: Results of long-term monitoring	26
Permanent conduction system pacing for congenitally corrected transposition of the great arteries: A Pediatric and Congenital Electrophysiology Society (PACES)/International Society for Adult Congenit	26
Does pulsed field ablation regress over time? A quantitative temporal analysis of pulmonary vein isolation	25
Pacing-induced cardiomyopathy: A systematic review and meta-analysis of definition, prevalence, risk factors, and management	25
Common wearable devices demonstrate variable accuracy in measuring heart rate during supraventricular tachycardia	25
Predictive value of atrial fibrillation during the postradiofrequency ablation blanking period	25
Determinants of outcome impact of vein of Marshall ethanol infusion when added to catheter ablation of persistent atrial fibrillation: A secondary analysis of the VENUS randomized clinical trial	25
Repeated exposure to transient obstructive sleep apnea–related conditions causes an atrial fibrillation substrate in a chronic rat model	25
Physical activity and atrial fibrillation: Data from wearable fitness trackers	24
Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19	24
Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with	24
Efficacy and safety of combined endocardial/epicardial catheter ablation for ventricular tachycardia in Chagas disease: A randomized controlled study	24
Epidemiology of cardiac implantable electronic device infections in the United States: A population-based cohort study	24
Nationwide burden of sudden cardiac death: A study of 54,028 deaths in Denmark	24
Effect of continuous positive airway pressure therapy on recurrence of atrial fibrillation after pulmonary vein isolation in patients with obstructive sleep apnea: A randomized controlled trial	24
Prevalence and outcome of early recurrence of atrial tachyarrhythmias in the Cryoballoon vs Irrigated Radiofrequency Catheter Ablation (CIRCA-DOSE) study	23
The role of long noncoding RNAs in atrial fibrillation	23
Cybersecurity: The need for data and patient safety with cardiac implantable electronic devices	23
Common and rare susceptibility genetic variants predisposing to Brugada syndrome in Thailand	23
Pacing in vasovagal syncope: Physiology, pacemaker sensors, and recent clinical trials—Precise patient selection and measurable benefit	23
Improving long QT syndrome diagnosis by a polynomial-based T-wave morphology characterization	23
Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease	23
Clinical profile and long-term follow-up of a cohort of patients with desmoplakin cardiomyopathy	23
Loss of ventricular preexcitation during noninvasive testing does not exclude high-risk accessory pathways: A multicenter study of WPW in children	23
Focal source and trigger mapping in atrial fibrillation: Randomized controlled trial evaluating a novel adjunctive ablation strategy	22
Identification of important risk factors for all-cause mortality of acquired long QT syndrome patients using random survival forests and non-negative matrix factorization	22
Role of angiopoietin-like protein 2 in atrial fibrosis induced by human epicardial adipose tissue: Analysis using an organo-culture system	22
Left ventricular summit arrhythmias with an abrupt V3 transition: Anatomy of the aortic interleaflet triangle vantage point	22
Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice	22
Relationship of paced left bundle branch pacing morphology with anatomic location and physiological outcomes	21
HRS/EHRA/APHRS/LAHRS/ACC/AHA worldwide practice update for telehealth and arrhythmia monitoring during and after a pandemic	21
2023 HRS/EHRA/APHRS/LAHRS expert consensus statement on practical management of the remote device clinic	21
Systematic quantification of histologic ventricular fibrosis in isolated mitral valve prolapse and sudden cardiac death	21
The role of timing in treatment of atrial fibrillation: An AFFIRM substudy	21
Remote and wearable ECG devices with diagnostic abilities in adults: A state-of-the-science scoping review	21
Mechanism and magnitude of bipolar electrogram directional sensitivity: Characterizing underlying determinants of bipolar amplitude	21
Safety of leadless pacemaker implantation in the very elderly	21
Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk	21
Initially unexplained cardiac arrest in children and adolescents: A national experience from the Canadian Pediatric Heart Rhythm Network	20
Epicardial course of the musculature related to the great cardiac vein: Anatomical considerations and clinical implications for mitral isthmus block after vein of Marshall ethanol infusion	20
High-density epicardial mapping in Brugada syndrome: Depolarization and repolarization abnormalities	20
Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices	20
Oral anticoagulants in extremely-high-risk, very elderly (>90 years) patients with atrial fibrillation	20
Defining idiopathic ventricular fibrillation: A systematic review of diagnostic testing yield in apparently unexplained cardiac arrest	20
Long-term survival following transvenous lead extraction: Importance of indication and comorbidities	20
The various manifestations of concealed nodofascicular/nodoventricular bypass tracts	20
Outer loop and isthmus in ventricular tachycardia circuits: Characteristics and implications	20
Ventricular tachycardia burden reduction after substrate ablation: Predictors of recurrence	20
Multisite conduction block in the epicardial substrate of Brugada syndrome	20
Self-reported physical activity and atrial fibrillation risk: A systematic review and meta-analysis	20
Altered heart rate variability in angiotensin II–mediated hypertension is associated with impaired autonomic nervous system signaling and intrinsic sinoatrial node dysfunction	20
Subcutaneous implantable cardioverter-defibrillator troubleshooting in patients with a left ventricular assist device: A case series and systematic review	19
Pectoral nerve blocks decrease postoperative pain and opioid use after pacemaker or implantable cardioverter–defibrillator placement in children	19
Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR/Cas9 gene editing in human-induced pluripotent stem cell–derived cardiomyocytes: Comparison of RyR2-R420Q,	19
Blood-based 8-hydroxy-2′-deoxyguanosine level: A potential diagnostic biomarker for atrial fibrillation	19
Connexin45 (GJC1) loss-of-function mutation contributes to familial atrial fibrillation and conduction disease	19
Combined epicardial and endocardial ablation for atrial fibrillation: Best practices and guide to hybrid convergent procedures	19
Frailty in patients undergoing percutaneous left atrial appendage closure	19
Ten-year outcomes of transcaval cardiac puncture for catheter ablation after extracardiac Fontan surgery	18

Long-term transesophageal echocardiography follow-up after percutaneous left atrial appendage closure	18
SCAI/HRS expert consensus statement on transcatheter left atrial appendage closure	18
Role of subcutaneous implantable loop recorder for the diagnosis of arrhythmias in Brugada syndrome: A United Kingdom single-center experience	18
Venous anatomy of the left ventricular summit: Therapeutic implications for ethanol infusion	18
2021 PACES Expert Consensus Statement on the Indications and Management of Cardiovascular Implantable Electronic Devices in Pediatric Patients: Executive Summary	18
Considerations for drug interactions on QTc interval in exploratory COVID-19 treatment	18
Pericardial effusion requiring intervention in patients undergoing percutaneous left atrial appendage occlusion: Prevalence, predictors, and associated in-hospital adverse events from 17,700 procedure	18
Gain in real-world cardiac resynchronization therapy efficacy with SyncAV dynamic optimization: Heart failure hospitalizations and costs	18
Individualized ablation strategy to treat persistent atrial fibrillation: Core-to-boundary approach guided by charge-density mapping	18
Effect of pacemaker implantation after transcatheter aortic valve replacement on long- and mid-term mortality	18
Comparison of the effect of glucose-lowering agents on the risk of atrial fibrillation: A network meta-analysis	18
B-PO03-131 EFFECTS OF CONTACT FORCE ON LESION SIZE DURING PULSED FIELD ABLATION	18
Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis	18
Is transesophageal echocardiography necessary in patients undergoing ablation of atrial fibrillation on an uninterrupted direct oral anticoagulant regimen? Results from a prospective multicenter regis	18
Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy—Are there predictors of appropriate therapy?	18
Critical repolarization gradients determine the induction of reentry-based torsades de pointes arrhythmia in models of long QT syndrome	17
Procedural and short-term follow-up outcomes of Amplatzer Amulet occluder versus Watchman FLX device: A meta-analysis	17
Sinus node exit, crista terminalis conduction, interatrial connection, and wavefront collision: Key features of human atrial activation in sinus rhythm	17
Age-related differences and associated mid-term outcomes of subcutaneous implantable cardioverter-defibrillators: A propensity-matched analysis from a multicenter European registry	17
Extracellular matrix remodeling precedes atrial fibrillation: Results of the PREDICT-AF trial	17
Double-balloon technique for retrograde venous ethanol ablation of ventricular arrhythmias in the absence of suitable intramural veins	17
Modern mapping and ablation techniques to treat ventricular arrhythmias from the left ventricular summit and interventricular septum	17
Programming implantable cardioverter–defibrillator in primary prevention: Guideline concordance and outcomes	16
2023 HRS expert consensus statement on the management of arrhythmias during pregnancy	16
Ventricular arrhythmias in athletes: Role of a comprehensive diagnostic workup	16
Dexmedetomidine versus propofol for operator-directed nurse-administered procedural sedation during catheter ablation of atrial fibrillation: A randomized controlled study	16
Pharmacological norepinephrine transporter inhibition for the prevention of vasovagal syncope in young and adult subjects: A systematic review and meta-analysis	16
Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: Insights from the Johns Hopkins ARVC Program	16
Relationship between device-detected burden and duration of atrial fibrillation and risk of ischemic stroke	16
Pursue physiological pacing therapy: A better understanding of left bundle branch pacing and left ventricular septal myocardial pacing	16
Safety and efficacy of leadless pacemaker for cardioinhibitory vasovagal syncope	16
Current of injury is an indicator of lead depth and performance during left bundle branch pacing lead implantation	16
Predictors of loss of capture in left bundle branch pacing: A multicenter experience	16
Exercise and arrhythmic risk in TMEM43 p.S358L arrhythmogenic right ventricular cardiomyopathy	16
Use of virtual visits for the care of the arrhythmia patient	16
Discrete sites of frequent premature ventricular complexes cluster within the infarct border zone and coincide with high frequency of delayed afterdepolarizations under adrenergic stimulation	16
Static magnetic field measurements of smart phones and watches and applicability to triggering magnet modes in implantable pacemakers and implantable cardioverter-defibrillators	16
Left atrial appendage occlusion using intracardiac echocardiography	16
Reconsidering the multiple wavelet hypothesis of atrial fibrillation	16
Effect of electrode size and spacing on electrograms: Optimized electrode configuration for near-field electrogram characterization	16
Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome	16
Absence of (sub-)acute cerebral events or lesions after electroporation ablation in the left-sided canine heart	16
Effects of pulsed field ablation on autonomic nervous system in paroxysmal atrial fibrillation: A pilot study	16
Sex differences in the origin of Purkinje ectopy-initiated idiopathic ventricular fibrillation	15
Catheter-free ablation of infarct scar through proton beam therapy: Tissue effects in a porcine model	15
Sudden cardiac arrest with shockable rhythm in patients with heart failure	15
Staphylococcus bacteremia without evidence of cardiac implantable electronic device infection	15
Tricuspid regurgitation outcomes in left bundle branch area pacing and comparison with right ventricular septal pacing	15
Long-term performance of a novel communicating antitachycardia pacing–enabled leadless pacemaker and subcutaneous implantable cardioverter-defibrillator system: A comprehensive preclinical study	15
Macroreentrant biatrial tachycardia relevant to interatrial septal incisions after mitral valve surgery: Electrophysiological characteristics and ablation strategy	15
Association between nocturnal heart rate variability and incident cardiovascular disease events: The HypnoLaus population-based study	15
Evaluation of age at symptom onset, proband status, and sex as predictors of disease severity in pediatric catecholaminergic polymorphic ventricular tachycardia	15
Morbidity and mortality in patients precluded for transvenous pacemaker implantation: Experience with a leadless pacemaker	15
Optimizing lead placement for pacing in dyssynchronous heart failure: The patient in the lead	15
Atrial arrhythmias and patient-reported outcomes in adults with congenital heart disease: An international study	15
Noninvasive electrocardiographic imaging–guided targeting of drivers of persistent atrial fibrillation: The TARGET-AF1 trial	15
2022 HRS expert consensus statement on evaluation and management of arrhythmic risk in neuromuscular disorders	15
Predicting atrial fibrillation using a combination of genetic risk score and clinical risk factors	15
Left ventricular endocardial pacing is less arrhythmogenic than conventional epicardial pacing when pacing in proximity to scar	15
Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises	15
Cardiac deceleration capacity as an indicator for cardioneuroablation in patients with refractory vasovagal syncope	14
Rate and nature of complications of conduction system pacing compared with right ventricular pacing: Results of a propensity score–matched analysis from a multicenter registry	14
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac	14
Vein of Marshall ethanol infusion in the treatment of atrial fibrillation: From concept to clinical practice	14
Outcomes of conduction system pacing for cardiac resynchronization therapy in patients with heart failure: A multicenter experience	14
Electrophysiological characteristics and possible mechanism of bipolar pacing in left bundle branch pacing	14
Evaluation of European Heart Rhythm Association consensus in patients with cardiovascular implantable electronic devices and Staphylococcus aureus bacteremia	14
Improvement in sudden cardiac death risk prediction by the enhanced American College of Cardiology/American Heart Association strategy in Chinese patients with hypertrophic cardiomyopathy	14
Anticoagulation for stroke prevention in patients with hypertrophic cardiomyopathy and atrial fibrillation: A review	14
Cardiac resynchronization therapy and ventricular tachyarrhythmia burden	14
Long-term outcomes of ventricular tachycardia substrate ablation incorporating hidden slow conduction analysis	14
Segmental nonocclusive cryoballoon ablation of pulmonary veins and extrapulmonary vein structures: Best practices III	14
Trends in utilization and spending on remote monitoring of pacemakers and implantable cardioverter–defibrillators among Medicare beneficiaries	14
Secretome of atrial epicardial adipose tissue facilitates reentrant arrhythmias by myocardial remodeling	14
Ambulatory atrioventricular synchronous pacing over time using a leadless ventricular pacemaker: Primary results from the AccelAV study	13
Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up	13
QT prolongation in patients with index evaluation for seizure or epilepsy is predictive of all-cause mortality	13
Intramyocardial mapping of ventricular premature depolarizations via septal venous perforators: Differentiating the superior intraseptal region from left ventricular summit origins	13
Implant, performance, and retrieval of an atrial leadless pacemaker in sheep	13
Biventricular endocardial pacing and left bundle branch area pacing for cardiac resynchronization: Mechanistic insights from electrocardiographic imaging, acute hemodynamic response, and magnetic reso	13
Feasibility of leadless left ventricular septal pacing with the WiSE-CRT system to target the left bundle branch area: A porcine model and multicenter patient experience	13
Distance between the lead-implanted site and tricuspid valve annulus in patients with left bundle branch pacing: Effects on postoperative tricuspid regurgitation deterioration	13
Incidence of new-onset atrial fibrillation after transcatheter patent foramen ovale closure using 15 years of Ontario administrative health data	13
Sinus Node Sparing Hybrid Thoracoscopic Ablation Outcomes in Patients with Inappropriate Sinus Tachycardia (SUSRUTA-IST) Registry	13
A phenotype-enhanced variant classification framework to decrease the burden of missense variants of uncertain significance in type 1 long QT syndrome	13
Simultaneous epicardial–endocardial mapping of the sinus node in humans with structural heart disease: Impact of overdrive suppression on sinoatrial exits	13
Preclinical safety and electrical performance of novel atrial leadless pacemaker with dual-helix fixation	13
Intentional nontherapy in long QT syndrome	13
Long-term prognosis of women with Brugada syndrome and electrophysiological study	13
Leadless left ventricular endocardial pacing for cardiac resynchronization therapy: A systematic review and meta-analysis	13
Purkinje system hyperexcitability and ventricular arrhythmia risk in type 3 long QT syndrome	13
Cardiovascular exercise as a treatment of postural orthostatic tachycardia syndrome: A pragmatic treatment trial	13
Very long term outcomes of atrial fibrillation ablation	13
Quality of life after the initial treatment of atrial fibrillation with cryoablation versus drug therapy	12
R-on-T and the initiation of reentry revisited: Integrating old and new concepts	12